BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
27.10.17 | Swiss Re Neutral | Credit Suisse Group | |
27.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
26.10.17 | UBS buy | UBS AG | |
26.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
26.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
26.10.17 | Swiss Re Reduce | Commerzbank AG | |
26.10.17 | Novartis Outperform | Bernstein Research | |
25.10.17 | Holcim Outperform | Bernstein Research | |
25.10.17 | UBS overweight | Morgan Stanley | |
25.10.17 | Zurich Insurance overweight | Barclays Capital | |
25.10.17 | Novartis Underweight | Barclays Capital | |
25.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
25.10.17 | Novartis buy | Société Générale Group S.A. (SG) | |
25.10.17 | Swiss Re Sector Perform | RBC Capital Markets | |
25.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
25.10.17 | Swiss Re overweight | Barclays Capital | |
25.10.17 | Swiss Re buy | Deutsche Bank AG | |
24.10.17 | Novartis Hold | S&P Capital IQ | |
24.10.17 | Novartis buy | Baader Bank | |
24.10.17 | UBS buy | HSBC | |
24.10.17 | Zurich Insurance Hold | Kepler Cheuvreux | |
24.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
24.10.17 | Nestlé Outperform | RBC Capital Markets | |
24.10.17 | UBS buy | Goldman Sachs Group Inc. | |
24.10.17 | UBS Neutral | Goldman Sachs Group Inc. | |
24.10.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.10.17 | Roche Neutral | UBS AG | |
23.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
23.10.17 | Novartis Neutral | UBS AG | |
23.10.17 | UBS buy | Citigroup Corp. | |
23.10.17 | UBS buy | Citigroup Corp. | |
23.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
23.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
23.10.17 | Swiss Re Hold | Jefferies & Company Inc. | |
23.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
20.10.17 | Roche Equal-Weight | Morgan Stanley | |
20.10.17 | Novartis overweight | Morgan Stanley | |
20.10.17 | Givaudan overweight | JP Morgan Chase & Co. | |
20.10.17 | Holcim Neutral | JP Morgan Chase & Co. | |
20.10.17 | Roche Hold | Deutsche Bank AG |